← back to search

Wayne Nicholls

University of Queensland · AU
Area of research
Oncology · Pulmonary and Respiratory Medicine
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Childhood Cancer Survivors' Quality of Life, Cancer Immunotherapy and Biomarkers, and CAR-T cell therapy research.
h-index
15
citations
1,049
works
46
NIH funding
primary concept
Medicine
email

Recent publications

Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk-Adapted Therapy: Results of an International Phase III Trial (SJMB03)
Journal of Clinical Oncology 2021cited by 231position: middledoi
Pembrolizumab in paediatric patients with advanced melanoma or a PD-L1-positive, advanced, relapsed, or refractory solid tumour or lymphoma (KEYNOTE-051): interim analysis of an open-label, single-arm, phase 1–2 trial
The Lancet Oncology 2019cited by 335position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Steven G. DuBois · Harvard University1 papers (2019–2019)Catherine Vézina · Montreal Children's Hospital1 papers (2019–2019) · 1 papers (2019–2019)Martin Ebinger · German Cancer Research Center1 papers (2019–2019) · 1 papers (2019–2019)Susan L. Cohn · AbbVie (United States)1 papers (2019–2019)Alberto S. Pappo · University of Tennessee Health Science Center1 papers (2019–2019)Elizabeth Fox · Children's Research Hospital1 papers (2019–2019)Birgit Geoerger · Institut Gustave Roussy1 papers (2019–2019)Jacek Toporski · Skåne University Hospital1 papers (2019–2019)Margaret E. Macy · University of Colorado Denver1 papers (2019–2019) · 1 papers (2019–2019)Scott J. Diede · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2019–2019)Julia Glade Bender · University of Otago1 papers (2019–2019)Navin Pinto · Asociación Civil Impacta Salud y Educación1 papers (2019–2019)Lynley V. Marshall · Royal Marsden NHS Foundation Trust1 papers (2019–2019)Theodore W. Laetsch · Children's Hospital of Philadelphia1 papers (2019–2019) · 1 papers (2019–2019)Kumudu Pathiraja · Merck & Co., Inc., Rahway, NJ, USA (United States)1 papers (2019–2019)